RIGL earnings call for the period ending June 30, 2020.
News & Analysis: Rigel Pharmaceuticals
The biotechnology company is hoping to improve coronavirus care.
RIGL earnings call for the period ending March 31, 2020.
Success in clinical trials doesn't guarantee success on the market.
RIGL earnings call for the period ending December 31, 2019.
Following the announced buyout of Dermira, Eli Lilly’s management said more acquisitions are in store for 2020.
Duking it out in two immune-related diseases, these biotechs couldn’t be more different.
The pharmaceutical stock is surging after providing preliminary results for the fourth quarter of 2019.
The real question is whether growing product sales can outpace increasing R&D expenses.
RIGL earnings call for the period ending September 30, 2019.